Cargando…

The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis

BACKGROUND: Inflammatory arthritis (IA) patients have been identified as at greater risk of severe illness from COVID-19. It is likely that lockdown restrictions (enforced by the UK government in response to the COVID-19 pandemic) and subsequent changes made to healthcare provision could impact pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Caton, Emma, Chaplin, Hema, Carpenter, Lewis, Sweeney, Melissa, Tung, Hsiu Yen, de Souza, Savia, Galloway, James, Nikiphorou, Elena, Norton, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522124/
https://www.ncbi.nlm.nih.gov/pubmed/34657629
http://dx.doi.org/10.1186/s41927-021-00231-1
_version_ 1784585032672739328
author Caton, Emma
Chaplin, Hema
Carpenter, Lewis
Sweeney, Melissa
Tung, Hsiu Yen
de Souza, Savia
Galloway, James
Nikiphorou, Elena
Norton, Sam
author_facet Caton, Emma
Chaplin, Hema
Carpenter, Lewis
Sweeney, Melissa
Tung, Hsiu Yen
de Souza, Savia
Galloway, James
Nikiphorou, Elena
Norton, Sam
author_sort Caton, Emma
collection PubMed
description BACKGROUND: Inflammatory arthritis (IA) patients have been identified as at greater risk of severe illness from COVID-19. It is likely that lockdown restrictions (enforced by the UK government in response to the COVID-19 pandemic) and subsequent changes made to healthcare provision could impact patients’ abilities to effectively manage their condition. The aim of this study was to qualitatively explore the impact of COVID-19 on self-management behaviours and healthcare access for people with IA. METHODS: Semi-structured interviews were conducted with 21 IA patients in June-July 2020, with nine follow-up interviews in November 2020. Interview schedules were developed with a Patient Research Partner and explored participants’ experiences of the COVID-19 pandemic. Interviews were conducted via telephone and analysed using inductive thematic analysis. RESULTS: Participants were aged between 24 and 79 years (mean = 50.1, SD = 15.8), largely female (71%) and White British (86%). Four initial themes were identified: (1) Impact of COVID-19 on medication adherence, (2) Impact of COVID-19 on physical activity, (3) Impact of COVID-19 on diet, and (4) Impact of COVID-19 on healthcare access and delivery. Subthemes focused on positive and negative changes made to these areas, as well as behaviours which remained consistent. Follow-up interviews highlighted differences in participants’ experiences during the two lockdown periods. CONCLUSION: COVID-19 has affected patients’ abilities to manage their IA. Healthcare professionals need to recognise the ongoing impact of COVID-19 on patient self-management and healthcare access to ensure that adequate understanding and support is available to patients who may have inadequate disease control as a result. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-021-00231-1.
format Online
Article
Text
id pubmed-8522124
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85221242021-10-18 The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis Caton, Emma Chaplin, Hema Carpenter, Lewis Sweeney, Melissa Tung, Hsiu Yen de Souza, Savia Galloway, James Nikiphorou, Elena Norton, Sam BMC Rheumatol Research BACKGROUND: Inflammatory arthritis (IA) patients have been identified as at greater risk of severe illness from COVID-19. It is likely that lockdown restrictions (enforced by the UK government in response to the COVID-19 pandemic) and subsequent changes made to healthcare provision could impact patients’ abilities to effectively manage their condition. The aim of this study was to qualitatively explore the impact of COVID-19 on self-management behaviours and healthcare access for people with IA. METHODS: Semi-structured interviews were conducted with 21 IA patients in June-July 2020, with nine follow-up interviews in November 2020. Interview schedules were developed with a Patient Research Partner and explored participants’ experiences of the COVID-19 pandemic. Interviews were conducted via telephone and analysed using inductive thematic analysis. RESULTS: Participants were aged between 24 and 79 years (mean = 50.1, SD = 15.8), largely female (71%) and White British (86%). Four initial themes were identified: (1) Impact of COVID-19 on medication adherence, (2) Impact of COVID-19 on physical activity, (3) Impact of COVID-19 on diet, and (4) Impact of COVID-19 on healthcare access and delivery. Subthemes focused on positive and negative changes made to these areas, as well as behaviours which remained consistent. Follow-up interviews highlighted differences in participants’ experiences during the two lockdown periods. CONCLUSION: COVID-19 has affected patients’ abilities to manage their IA. Healthcare professionals need to recognise the ongoing impact of COVID-19 on patient self-management and healthcare access to ensure that adequate understanding and support is available to patients who may have inadequate disease control as a result. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-021-00231-1. BioMed Central 2021-10-18 /pmc/articles/PMC8522124/ /pubmed/34657629 http://dx.doi.org/10.1186/s41927-021-00231-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Caton, Emma
Chaplin, Hema
Carpenter, Lewis
Sweeney, Melissa
Tung, Hsiu Yen
de Souza, Savia
Galloway, James
Nikiphorou, Elena
Norton, Sam
The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title_full The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title_fullStr The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title_full_unstemmed The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title_short The impact of COVID-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
title_sort impact of covid-19 on self-management behaviours and healthcare access for people with inflammatory arthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522124/
https://www.ncbi.nlm.nih.gov/pubmed/34657629
http://dx.doi.org/10.1186/s41927-021-00231-1
work_keys_str_mv AT catonemma theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT chaplinhema theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT carpenterlewis theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT sweeneymelissa theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT tunghsiuyen theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT desouzasavia theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT gallowayjames theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT nikiphorouelena theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT nortonsam theimpactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT catonemma impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT chaplinhema impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT carpenterlewis impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT sweeneymelissa impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT tunghsiuyen impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT desouzasavia impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT gallowayjames impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT nikiphorouelena impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis
AT nortonsam impactofcovid19onselfmanagementbehavioursandhealthcareaccessforpeoplewithinflammatoryarthritis